Genomic Valley Biotech Ltd — Important, 10-10-2025: Company Update

Genomic Valley Biotech's Registrar and Share Transfer Agent has confirmed compliance for the recent quarter. They processed all securities received for dematerialization, confirming acceptance or rejection to depositories, and ensured these securities are listed on stock exchanges. Physical certificates were mutilated and cancelled after verification, with depositories' names updated in the register of members within 15 days. This confirms efficient handling of shareholder dematerialization requests, crucial for accurate shareholding records and investor trust.